Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study

Table 6

Characteristics at baseline after PSM: Xiyanping combination versus antiviral.

Variable	Xiyanping combination		Antiviral		P
	N	%	N	%
Sample size	43		43
Age (y), mean ± SD	52.21±19.54		54.70±21.70		0.578
Gender
Male	21	48.8%	23	53.5%	0.666
Female	22	51.2%	20	46.5%	0.666
Marriage
Widowed	38	90.5%	37	90.2%	0.971
Married	4	9.5%	4	9.8%	0.971
Single	0	0.0%	0	0.0%	0
Divorced or others	0	0.0%	0	0.0%	0
Occupation
Peasants	4	9.3%	5	11.6%	0.725
Employment	24	61.5%	23	60.5%	0.829
Unemployment	7	41.2%	5	26.3%	0.534
Retirement	1	2.0%	2	3.8%	0.557
Unknown	4	8.0%	5	9.8%	0.725
Others	3	6.5%	3	6.5%	1
Comorbidities
Yes	2	4.7%	4	9.3%	0.397
No	41	95.3%	39	90.7%	0.397
CRP difference	35.42±39.00		34.74±43.86		0.950
Neutrophil proportion difference	74.32±16.16		75.39±9.40		0.730
Neutrophil count difference	6.07±3.09		5.56±2.00		0.410
White blood cell count difference	7.99±3.42		7.33±2.19		0.330